Facilitating treatment of anxiety disorders in patients with comorbid medical illness

Current Psychiatry Reports

Volumn 7, Issue 3, 2005, Pages 228-235

  Hicks, Daniel W ^a   Raza, Haniya ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIARRHYTHMIC AGENT; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; ANTIMYCOBACTERIAL AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUSPIRONE; CANNABINOID DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN DERIVATIVE; FLURAZEPAM; GONADORELIN; HALOPERIDOL; HISTAMINE H2 RECEPTOR ANTAGONIST; HYPNOTIC SEDATIVE AGENT; INTERFERON; LORAZEPAM; METHYLXANTHINE; NANDROLONE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE; OPIATE; OPIATE ANTAGONIST; OXAZEPAM; PROGESTERONE DERIVATIVE; QUETIAPINE; RISPERIDONE;

ANXIETY DISORDER; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; COPING BEHAVIOR; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MECHANISM; DRUG METABOLISM; ENDOCRINE DISEASE; EXTRAPYRAMIDAL SYMPTOM; FEEDBACK SYSTEM; FREQUENCY ANALYSIS; FUNCTIONAL DISEASE; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH PRACTITIONER; HOSPITALIZATION; HUMAN; HYPNOSIS; INFLAMMATORY DISEASE; MEDITATION; METABOLIC DISORDER; NEUROLOGIC DISEASE; PATIENT EDUCATION; PHYSICAL DISEASE; PRIMARY MEDICAL CARE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; RESPIRATORY TRACT DISEASE; REVIEW; SEDATION; SURGERY;

EID: 21444441870     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-005-0058-8     Document Type: Review

References (53)

1. House A, Stark D: Anxiety in medical patients. Br Med J 2002, 325:207-209.
2. Epstein SA, Hicks DW: Anxiety Disorders. In The American Psychiatric Textbook of Psychosomatic Medicine. Edited by Levenson J. Washington, DC: APPI Press; 2004: 314.
3. First MB, et al.: Anxiety disorders. In A Quick Reference to the Diagnostic Criteria from DSM-IV-R. Edited by First MB. Washington DC: APPI Press; 2000:209-227.
4. Kessler RC, McGonagle KA, Zhao S, et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-19.
5. Roy-Byrne PP, Wagner A: Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry 2004, 65(Suppl 13):20-26.
6. Beitman BD, Kushner MG, Basha I, et al.: Follow-up status of patients with angiographically normal coronary arteries and panic disorder. JAMA 1991, 265:1545-1549.
7. Kroenke K, Jackson JL, Chamberlain J: Depressive and anxiety disorders in patients presenting wit physical complaints: clinical predictors and outcome. Am J Med 1997, 103:339-347.
8. Kerrihard T, Breitbart W, Dent R, Strout D: Anxiety in patients with cancer and human immunodefieciency virus. Semin Clin Neuropsychiatry 1999, 4:114-132.
9. Wise MG, Rundell JR: Anxiety and neurological disorders. Semin Clin Neuropsychiatry 1999, 4:98-102.
10. Sherbourne CD, Wells KB, Meredith LS, et al.: Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry 1996, 53:889-895.
11. Zaubler T, Katon W: Panic disorder in the general medical setting. J Psychosom Res 1998, 44:25-42.
12. Ballenger JC: Treatment of panic disorder in the general medical setting. J Psychosom Res 1998, 44:5-15.
13. Regier DA, Goldberg ID, Taube CA: The de facto US mental health services system: a public health perspective. Arch Gen Psychiatry 1978, 35:685-693.
14. Harman JS, Rollman BL, Hanusa BH, et al.: Physician office visits of adults for anxiety disorders in the United States, 1985-1998. J Gen Intern Med 2002, 17:165-172.
15. Briggs KW, Goldberg DP: Somatic presentation of DSM III psychiatric disorders in primary care. J Psychosom Res 1985, 29:563-569.
16. Wittchen H-U, Kessler RC, Beesdo K, et al.: Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry 2002, 63:24-34.
17. Fifer SK, Mathias SD, Patrick DL, et al.: Untreated anxiety among adult primary care patients in a Health Maintenance Organization. Arch Gen Psychiatry 1994, 51:740-750.
18. Barsky AJ, Borus JF: Functional somatic syndromes. Ann Intern Med 1999, 130:910-921.
19. Hudson JI, Hudson MS, Pliner LF, et al.: Fibromyalgia and major affective disorder: a controlled phenomenology and family history study.Am J Psychiatry 1985, 142:441-446.
20. Katon WJ, Sullivan M, Walker E: Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med 2001, 134(Suppl 9):917-925.
21. Walker EA, Gelfand A, Katon W, et al.: Adult health status of women with histories of childhood abuse and neglect. Am J Med 1999, 107:332-339.
22. Hyams KC, Wignall FS, Roswell R: War syndromes and their evaluation; from the US Civil War to the Persian Gulf War. Ann Intern Med 1996, 125:398-405.
23. Arnold LM: Antidepressants for fibromyalgia: latest word on the link to depression and anxiety. Curr Psychiatry 2002, 1:49-54.
24. Satel SL: When disability benefits make patients sicker. N Engl J Med 1995, 333:794-796.
25. Sharpe M, Carson A: "Unexplained" somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift? Ann Intern Med 2001, 134:926-930.
26. Williams DA, Cary MA, Groner KH, et al.: Anxiety in patients with cancer and human immunodefieciency virus. J Rheumatol 2002, 29:1280-1286.
27. Crowe RR, Noyes R, Pauls DL, et al.: A family study of panic disorder. Arch Gen Psychiatry 1983, 40:1065-1069.
28. Torgerson S: Genetic factors in anxiety disorders. Arch Gen Psychiatry 1983, 40:1085-1092.
29. Leckman JF, Wissman MM, Merikangas KR, et al.: Panic disorder and major depression. Arch Gen Psychiatry 1983, 40:1055-1060.
30. Katon WJ: Panic Disorder in the Medical Setting. Washington DC: National Institutes of Health Publication, No. 94-3482, 1994.
31. Walker EA, Roy-Byrne PP, Katon WJ: Irritable bowel illness syndrome and psychiatric illness. Am J Psychiatry 1990, 147:565-572.
32. Katon WJ: Anxiety in the medically ill. American Board of Psychiatry and Neurology, Psychosomatic Medicine Subspecialty Board Review Course, Florida, 2004.
33. Barsky AJ, Cleary PD, Coeytaux RR, et al.: The clinical outcomes of palpitations in medical outpatients. Arch Intern Med 1995, 155:1782-1788.
34. Kawachi I, Colditz GA, Ascherio A, et al.: Prospective study of phobic anxiety and risk of coronary artery disease in men. Circulation 1994, 89:1992-1997.
35. Smoller JW, Simon NM, Pollack MH, et al.: Anxiety in patients with pulmonary disease: comorbidity and treatment. Semin Clin Neuropsychiatry 1999, 4:84-97.
36. Daly KA, Kushner MG, Clayon PJ, et al.: Seizure disorder is in the differential diagnosis of panic disorder. Psychosomatics 2000, 41:436-438.
37. Schiffer RB: Anxiety disorders in Parkinsons disease; insights into the neurobiology of neurosis. J Psychosom Res 1999, 47:505-508.
38. Castillo C, Starkstein SE, Fedoroff JP, et al.: Generalized anxiety disorder after stroke. J Nerv Ment Dis 1993, 181:100-106.
39. Young AS, Klap R, Sherbourne CD, et al.: The quality of care for depressive and anxiety disorders in the US. Arch Gen Psychiatry 2001, 58:55-61.
40. Meredith LS, Sherbourne CD, Jackson CA, et al.: Treatment typically provided for cormorbid anxiety disorders. Arch Fam Med 1997, 6:231-237.
41. Stein MB, Sherbourne CD, Craske MG, et al.: Quality of care for primary care patients with anxiety disorders. Am J Psychiatry 2004, 161:2230-2237.
42. Roy-Byrne PP, Stein MB, Russo J, et al.: Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry 2000, 60:492-499.
43. Maier W, Gansicke M, Freyberger HJ, et al.: Generalized anxiety disorder in primary care from a cross-cultural perspective: a valid diagnostic entity? Acta Psychiatr Scand 2000, 101:29-36.
44. McDonald-Haile J, Bradley LA, Bailey MA, et al.: Relaxation training reduces symptom reports and acid exposure in patients with gastroesophageal reflux disease. Gasteroenterology 1994, 107:619-620.
45. Acosta F: Biofeedback and progressive relaxation in weaning the anxious patient from the ventilator. Heart Lung 1988, 17:299-301.
46. Domar AD, Noe JM, Benson H: The preoperative use of the relaxation response with ambulatory surgery patients. Hosp Top 1987, 65:30-35.
47. Katon WF, Von Korff M, Lin E, et al.: Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990, 12:355-362.
48. Kroenke K, Spitzer RL, Williams JB, et al.: Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994, 3:774-779.
49. Spitzer RL, Kroenke K, Williams JB, et al.: Validation and utility of a self-report version of the PRIME-MD: the PHQ primary care study. JAMA 1999, 282:1737-1744.
50. Katon W, Roy-Byrne PP, Russo J, et al.: Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Arch Gen Psychiatry 2002, 59:1098-1104.
51. Roy-Byrne PP, Katon WJ, Cowley DS, et al.: A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care. Arch Gen Psychiatry 2001, 58:869-876.
52. Rollman BL, Herbeck BB, Reynolds CF, et al.: A contemporary protocol to assist primary care physicians in the treatment of panic and generalized anxiety disorders. Gen Hosp Psychiatry 2003, 25:74-82.
53. Simon GE, Ludman EJ, Tutty S, et al.: Telephone psychotherapy and telephone care management for primary care patients starting antidepressant treatment. JAMA 2004, 292:35-42.